Načítá se...
Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer
Lung cancer is the leading cause of cancer-related deaths, demanding improvement in current treatment modalities to reduce the mortality rates. Lung cancer is divided into two major classes with non-small cell lung cancer representing ~84% of lung cancer cases. One strategy widely used to treat non-...
Uloženo v:
| Vydáno v: | Biochem Pharmacol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854807/ https://ncbi.nlm.nih.gov/pubmed/32681833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2020.114154 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|